Biologic Medications for Psoriasis Market Expanding at 7.8% CAGR from 2026–2034 with Strong Industry Adoption
 According to a new report from Intel Market Research, the global biologic medications for psoriasis market was valued at USD 14.5 billion in 2025 and is projected to reach USD 28.7 billion by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is fueled by increasing psoriasis prevalence, superior efficacy of...
0 Comments 0 Shares 118 Views
Isfidev Developer